Psychosis News and Research RSS Feed - Psychosis News and Research

Psychosis means abnormal condition of the mind, and is a generic psychiatric term for a mental state often described as involving a "loss of contact with reality". People suffering from psychosis are said to be ''psychotic.''
Researchers analyze post-Ebola syndrome survivors to improve ongoing treatment

Researchers analyze post-Ebola syndrome survivors to improve ongoing treatment

Researchers from the University of Liverpool and the King's Sierra Leone Partnership are to present new findings into post-Ebola syndrome at a major European conference this week. [More]
FDA proposes to change regulation of ECT treatment

FDA proposes to change regulation of ECT treatment

For decades, people with severe depression, bipolar disorder, and other major mental health conditions have gotten help from the treatment known as ECT, when nothing else helped them. [More]
Warning of increased mortality risk for PD patients taking antipsychotics

Warning of increased mortality risk for PD patients taking antipsychotics

Researchers have found a more than twofold increase in the risk of death among patients with Parkinson's disease who take antipsychotics, particularly typical antipsychotics. [More]
Antipsychotic drugs may do significantly more harm to Parkinson's disease patients

Antipsychotic drugs may do significantly more harm to Parkinson's disease patients

At least half of Parkinson's disease patients experience psychosis at some point during the course of their illness, and physicians commonly prescribe antipsychotic drugs, such as quetiapine, to treat the condition. However, a new study by researchers at the Perelman School of Medicine at the University of Pennsylvania, the University of Michigan Medical School, and the Philadelphia and Ann Arbor Veterans Affairs Medical Centers and suggests that these drugs may do significantly more harm in a subset of patients. [More]
Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba

Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba

Orexigen Therapeutics, Inc. today announced Valeant Pharmaceuticals International, Inc. will commercialize Mysimba (naltrexone HCl / bupropion HCl prolonged release) in Central and Eastern Europe. [More]
Exercise programme reduces symptoms among young adults with first-episode psychosis

Exercise programme reduces symptoms among young adults with first-episode psychosis

An exercise programme devised by researchers at the University of Manchester has dramatically reduced symptoms among young people with first-episode psychosis. [More]
Studies raise hope for new treatments, preventive approaches for schizophrenia

Studies raise hope for new treatments, preventive approaches for schizophrenia

Emerging evidence on the development, "prodromal" characteristics, and long-term course of schizophrenia provide reasons for optimism for developing new treatments and preventive approaches for this devastating disorder, according to the special March/April issue of Harvard Review of Psychiatry. [More]
Study finds strong link between postpartum disorder and suicide risk in new mothers

Study finds strong link between postpartum disorder and suicide risk in new mothers

Over a period spanning four decades, a total of eight Danish women committed suicide within a year of being diagnosed with a birth-related psychiatric disorder, including severe episodes of postpartum depression or psychosis. [More]
Early intervention treatment at home, school can help young people with psychotic-like symptoms

Early intervention treatment at home, school can help young people with psychotic-like symptoms

Young people with mental problems - especially those with psychotic-like symptoms - should receive help as early as possible and in their own environment. This was the conclusion of a joint study of the University of Helsinki, the Helsinki University Hospital Department of Psychiatry and the National Institute for Health and Welfare, Finland. [More]
Antibiotics may be linked to delirium and other brain problems

Antibiotics may be linked to delirium and other brain problems

Antibiotics may be linked to a serious disruption in brain function, called delirium, and other brain problems, more than previously thought, according to a "Views and Reviews" article published in the February 17, 2016, online issue of Neurology, a medical journal of the American Academy of Neurology. [More]
AKT1 gene moderates mind-altering effects of smoking cannabis in young people

AKT1 gene moderates mind-altering effects of smoking cannabis in young people

Researchers at the University of Exeter and UCL (University College London) have identified a gene which can be used to predict how susceptible a young person is to the mind-altering effects of smoking cannabis. The finding could help identify otherwise healthy users who are most at risk of developing psychosis. [More]
Coordinated specialty care more cost-effective for young people with first episode psychosis

Coordinated specialty care more cost-effective for young people with first episode psychosis

New analysis from a mental health care study shows that "coordinated specialty care" (CSC) for young people with first episode psychosis is more cost-effective than typical community care. Cost-effectiveness analysis in health care is a way to compare the costs and benefits of two or more treatment options. [More]
Frequent traumatic experiences throughout infancy increase risk of psychosis during adulthood

Frequent traumatic experiences throughout infancy increase risk of psychosis during adulthood

A research carried out with participation of the University of Granada proves that suffering repeated traumatic experiences throughout infancy and adolescence multiplies by 7 the risk of suffering psychosis during adulthood. [More]
Research offers novel insights into root causes of schizophrenia

Research offers novel insights into root causes of schizophrenia

Schizophrenia is a mysterious and devastating disorder that afflicts one percent of the adult population worldwide. Its symptoms — hallucinations, emotional withdrawal, and cognitive impairment — are chronic and typically emerge just as individuals are entering adulthood. Today's medications treat just one of these symptoms (psychosis); treatments for the underlying disease and its many other symptoms have been hard to develop, because no one really understands what causes the disorder. [More]
Citalopram of limited use for dementia-associated agitation

Citalopram of limited use for dementia-associated agitation

The use of citalopram for the treatment of agitation in Alzheimer’s disease may be limited to a small group of people with moderate agitation and low levels of cognitive impairment, study findings suggest. [More]
Diseases that cause skin-related problems can also trigger serious neurological conditions

Diseases that cause skin-related problems can also trigger serious neurological conditions

Diseases such as lupus that cause rashes and other skin problems also can trigger migraine headaches, strokes and other serious neurological conditions, according to an article by Loyola University Medical Center physicians. [More]
Gene variant linked to psychotic symptoms, cognitive impairment in people with bipolar disorder identified

Gene variant linked to psychotic symptoms, cognitive impairment in people with bipolar disorder identified

Researchers at Karolinska Institutet, and the Sahlgrenska Academy at Gothenburg University in Sweden have identified a gene variant linked to psychotic symptoms and cognitive impairment in people with bipolar disorder. The study, which is published in the journal Molecular Psychiatry, describes a possible mechanism for how the gene variant produces clinical symptoms by affecting levels of specific proteins in the brain. [More]
LSD reduces connectivity within human brain networks

LSD reduces connectivity within human brain networks

LSD is known to cause changes in consciousness, including "ego-dissolution", or a loss of the sense of self. Despite a detailed knowledge of the action of LSD at specific serotonin receptors, it has not been understood how this these pharmacological effects can translate into such a profound effect on consciousness. [More]
Biotypes can identify distinct subgroups of psychosis

Biotypes can identify distinct subgroups of psychosis

Three biomarker-based categories, called biotypes, outperformed traditional diagnoses, such as schizophrenia and bipolar disorder with psychosis, in sorting psychosis cases into distinct subgroups on the basis of brain biology, report researchers funded by the National Institutes of Health. [More]
Groundbreaking study establishes empirical biomarkers to aid in diagnosis, treatment of psychosis

Groundbreaking study establishes empirical biomarkers to aid in diagnosis, treatment of psychosis

In a groundbreaking study led by UT Southwestern Medical Center, a comprehensive set of empirical biomarkers has been established to aid in diagnosis and treatment of psychosis. [More]
Advertisement
Advertisement